Replacement of Gabapentin with Pregabalin in Postherpetic Neuralgia Therapy

Pain Medicine

Volumn 12, Issue 7, 2011, Pages 1112-1116

  Ifuku, Masataka ^a   Iseki, Masako ^a   Hidaka, Ikuhiro ^a   Morita, Yoshihito ^a   Komatus, Syuji ^a   Inada, Eiichi ^a  

^a JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Gabapentin; Postherpetic Neuralgia; Pregabalin

Indexed keywords

ANTIARRHYTHMIC AGENT; GABAPENTIN; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE; PREGABALIN; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT;

ADULT; AGED; ANALGESIC ACTIVITY; ARTICLE; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; DIZZINESS; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG SUBSTITUTION; FEMALE; HUMAN; MALE; PAIN ASSESSMENT; PERIPHERAL EDEMA; POSTHERPETIC NEURALGIA; SOMNOLENCE; VISUAL ANALOG SCALE;

EID: 79960373700     PISSN: 15262375     EISSN: 15264637     Source Type: Journal    
DOI: 10.1111/j.1526-4637.2011.01162.x     Document Type: Article

References (19)

1. Beutner KR, Friedman DJ, Forszpaniak C, etal. Valaciclovir compared with acyclovir for improved therapy for herpes zoster immunocompetent adult. Antimicrob Agents Chemother 1995;39:1546-53.
2. Benzon HT, Chekka K, Darnule A, etal. The prevention and management of postherpetic neuralgia with emphasis on interventional procedures. Reg Anesth Pain Med 2009;34:514-21.
3. Rice AS, Maton S. Gabapentin in postherpetic neuralgia: A randomized, double blind, placebo controlled study. Pain 2001;94:215-24.
4. Rowbotham M, Harden N, Stacey B, etal. Gabapentin for the treatment of postherpetic neuralgia: A randomized controlled trial. JAMA 1998;280:1837-42.
5. Dworkin RH, Corbin AE, Young JP Jr, etal. Pregabalin for treatment of postherpetic neuralgia: A randomized, placebo-controlled trial. Neurology 2003;60:1274-83.
6. Sabatowski R, Galvez R, Cherry DA, etal. Pregabalin reduces pain and improves sleep and mood disturbances in patients with postherpetic neuralgia: Results of a randomized, placebo-controlled clinical trial. Pain 2004;109:26-35.
7. O'Connor AB, Dworkin RH. Treatment of neuropathic pain: An overview of recent guidelines. Am J Med 2009;122:22-32.
8. Attal N, Cruccu G, Haanpaa M, etal. EFNS guidelines on pharmacological treatment of neuropathic pain. Eur J Neurol 2006;13:1153-69.
9. Dworkin RH, O'Connor AB, Backonja M, etal. Pharmacologic management of neuropathic pain: Evidence-based recommendations. Pain 2007;132:237-51.
10. Finnerup NB, Otto M, McQuay HJ, etal. Algorithm for neuropathic pain treatment: An evidence based proposal. Pain 2005;118:289-305.
11. McLean MJ. Clinical pharmacokinetics of gabapentin. Neurology 1994;44:S17-22. discussion S31-12.
12. Ben-Menachem E. Pregabalin pharmacology and its relevance to clinical practice. Epilepsia 2004;45:13-8.
13. Glion I. Gabapentin and pregabalin for chronic neuropathic acid early postsurgical pain: Current evidence and future directions. Curr Opin Anaesthesiol 2007;20:456-72.
14. Chiechio S, Zammataro M, Caraci F, etal. Pregabalin in the treatment of chronic pain: An overview. Clin Drug Investig 2009;29:203-13.
15. Ogawa S, Suzuki M, Arakawa A, etal. Efficacy and tolerability of pregabalin for postherpetic neuralgia: A multicenter, randomized, double-blind, placebo-controlled clinical trial. JJSPC 2010;17:141-52.
16. Moore RA, Straube S, Wiffen PJ, etal. Pregabalin for acute and chronic pain in adults. Cochrane Database Syst Rev 2009;(3):CD007076.
17. Toth C. Substitution of gabapentin therapy with pregabalin therapy in neuropathic pain due to peripheral neuropathy. Pain Med 2010;11:456-65.
18. Israili ZH, Hall WD. Cough and angioneurotic edema associated with angiotensin-coverting enzyme inhibitor therapy. Ann Intern Med 1992;117:234-42.
19. Dooley DJ, Donovan CM, Meder WP, etal. Preferential action of gabapentin and pregabalin at P/Q-type voltage-sensitive calcium channels. Synapse 2002;45:171-90.